Clinical Trial Update: A Study of Guselkumab in Adult Participants With Celiac Disease [Phase 1]

View source ↗

Summary

The Phase 1 trial of guselkumab in adults with celiac disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Celiac Disease | Phase 1 | Status: WITHDRAWN